Goldman Sachs Group Inc Ligand Pharmaceuticals Inc Transaction History

Goldman Sachs Group Inc

  • $613 Billion
  • Q4 2024

A detailed history of Goldman Sachs Group Inc transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Goldman Sachs Group Inc holds 110,609 shares of LGND stock, worth $13.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
110,609
Previous 95,253 16.12%
Holding current value
$13.5 Million
Previous $9.54 Million 24.21%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025
BUY
$99.95 - $129.9 $1.53 Million - $1.99 Million
15,356 Added 16.12%
110,609 $11.9 Million
Q3 2024

Nov 14, 2024
BUY
$82.7 - $110.11 $2.54 Million - $3.38 Million
30,656 Added 47.46%
95,253 $9.54 Million
Q2 2024

Aug 13, 2024
BUY
$68.53 - $87.91 $513,015 - $658,094
7,486 Added 13.11%
64,597 $5.44 Million
Q1 2024

May 15, 2024
SELL
$68.64 - $89.2 $464,349 - $603,438
-6,765 Reduced 10.59%
57,111 $4.17 Million
Q4 2023

Feb 13, 2024
SELL
$49.57 - $72.63 $295,685 - $433,237
-5,965 Reduced 8.54%
63,876 $4.56 Million
Q3 2023

May 14, 2024
BUY
$58.86 - $72.67 $351,099 - $433,476
5,965 Added 9.34%
69,841 $4.18 Million
Q3 2023

Nov 14, 2023
SELL
$58.86 - $72.67 $2.18 Million - $2.69 Million
-36,953 Reduced 34.6%
69,841 $4.18 Million
Q2 2023

May 14, 2024
BUY
$69.53 - $79.33 $3.12 Million - $3.55 Million
44,803 Added 72.27%
106,794 $7.7 Million
Q2 2023

Aug 14, 2023
BUY
$69.53 - $79.33 $3.12 Million - $3.55 Million
44,803 Added 72.27%
106,794 $7.7 Million
Q1 2023

May 14, 2024
BUY
$65.67 - $77.08 $16,154 - $18,961
246 Added 0.4%
61,991 $4.56 Million
Q1 2023

May 11, 2023
BUY
$65.67 - $77.08 $16,154 - $18,961
246 Added 0.4%
61,991 $4.56 Million
Q4 2022

May 14, 2024
BUY
$61.72 - $96.74 $1.6 Million - $2.51 Million
25,987 Added 72.67%
61,745 $4.12 Million
Q4 2022

Feb 13, 2023
BUY
$61.72 - $96.74 $1.6 Million - $2.51 Million
25,987 Added 72.67%
61,745 $4.12 Million
Q3 2022

May 14, 2024
SELL
$0.01 - $107.56 $77 - $837,677
-7,788 Reduced 17.88%
35,758 $3.08 Million
Q3 2022

Nov 10, 2022
SELL
$0.01 - $107.56 $77 - $837,677
-7,788 Reduced 17.88%
35,758 $3.08 Million
Q2 2022

May 14, 2024
SELL
$74.52 - $117.06 $1.51 Million - $2.38 Million
-20,330 Reduced 31.83%
43,546 $3.89 Million
Q2 2022

Aug 15, 2022
SELL
$74.52 - $117.06 $768,524 - $1.21 Million
-10,313 Reduced 19.15%
43,546 $3.89 Million
Q1 2022

May 16, 2022
SELL
$94.99 - $151.56 $3.23 Million - $5.16 Million
-34,017 Reduced 38.71%
53,859 $6.06 Million
Q4 2021

Feb 14, 2022
BUY
$127.69 - $165.85 $3.51 Million - $4.56 Million
27,519 Added 45.59%
87,876 $13.6 Million
Q3 2021

Nov 10, 2021
BUY
$102.33 - $144.73 $6.18 Million - $8.74 Million
60,357 New
60,357 $8.41 Million

Others Institutions Holding LGND

# of Institutions
275
Shares Held
18.5M
Call Options Held
30.8K
Put Options Held
5.2K
View Full List

About LIGAND PHARMACEUTICALS INC

LGND Quotes by TradingView
  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $2.06B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email